Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Phase 2Efficacy & side effects
1(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

unknown1
Recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (100.0%)

Trials by Status

unknown133%
recruiting133%
completed133%

Recent Activity

1 active trials
Showing 3 of 3
completedphase_2

Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers

NCT04535414
recruiting

Microbiota in Gastric Cancer by Gastric Mucosal Brushing

NCT06325891
unknown

The Role of Narrow-Band Imaging Endoscopy in Diagnosing Gastric Intestinal Metaplasia

NCT00673699

Clinical Trials (3)

Showing 3 of 3 trials
NCT04535414Phase 2

Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers

Completed
NCT06325891

Microbiota in Gastric Cancer by Gastric Mucosal Brushing

Recruiting
NCT00673699

The Role of Narrow-Band Imaging Endoscopy in Diagnosing Gastric Intestinal Metaplasia

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3